What does SSTI stand for?

Skin and Skin Structure Infection

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Ship Service Turbo Generator Ships Service Turbine Generator Social Skills Training Group Space and Systems Technology Group (Motorola) Stanton Street Technology Group (web design; El Paso, TX) So Sweet the Hour (band) Swiss School of Tourism and Hospitality Satellite-to-Satellite Tracking Instrument Simulation Systems Technologies, Inc (Voorhees, NJ) Six Sigma Technical Institute (Motorola, Inc.)		Skin and Soft Tissue Infection Small Spacecraft Technology Initiative State Science & Technology Institute (Westerville, OH) Sub Sea Tie In South Sound Traditional Inuit Kayak Symposium (Twanoh State Park, WA) Sea Surface Temperature Imaging Radiometer Small Ship Teletype Information Exchange System Self-Service Time & Leave (University of Virginia; Charlottesville, VA) Site Specific Target Level Solid State Track Link

Samples in periodicals archive:

Byline: nitesh03 Basilea Pharmaceutica has reported that the FDA has issued an approvable letter for ceftobiprole, a broad-spectrum cephalosporin, for the treatment of complicated skin and skin structure infections including diabetic foot infections.

United States: Basileas ceftobiprole receives FDA approvable letter

Ceftobiprole demonstrated high cure rates in patients with complicated skin and skin structure infections due to Gram- positive pathogens.

BASILEA REPORTS 92% CLINICAL CURE RATES FOR CEFTOBIPROLE

Telavancin, which is a lipoglycopeptide injectable antibiotic, is currently in phase 3 studies for the treatment of complicated skin and skin structure infections (cSSSI) and Hospital-acquired pneumonia (HAP) conducted in the US.

Astellas Pharma, Theravance to Enter into Licensing Agreement for ...

EDT Oritavancin Demonstrated Efficacy with 3-7 Day Therapy in Two Phase 3 Trials for cSSSI Poster L-1514 is entitled, "Oritavancin in the treatment of complicated skin and skin structure infections (cSSSI): Combined results of two Phase 3 multinational trials.

Targanta Presents Efficacy and Safety Data for Oritavancin for the ...

and EU regulatory approval for the treatment of Complicated Skin and Skin Structure Infections (cSSSI), and, a program to develop an oral version of oritavancin for the treatment of Clostridium difficile.

Targanta Therapeutics to Present at Canaccord Adams Anti-Infectives ...

NEW YORK -- Pfizer Inc today announced it will globally withdraw all dalbavancin marketing applications for the treatment of complicated skin and skin structure infections in adults, including the U.

Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to ...

In its intravenous (IV) formulation, the product candidate has been tested in over 2,100 individuals and has completed two Phase 3 studies for the treatment of complicated skin and skin structure infections (cSSSI) in which the primary endpoints were met.

Targanta Submits Marketing Authorization Application for Oritavancin

The oritavancin NDA was submitted in early February seeking approval of the intravenous antibiotic for the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive organisms, including methicillin-resistant Staphylococcus aureus, or MRSA.

Targanta Announces FDA Acceptance of Oritavancin New Drug Application